Join us in Basel for our next Women’s Life Sciences Network event. The panel will discuss key considerations related to authority expectations as well as challenges, and potential strategies for EU regulatory and competition law compliance for combination therapies. Speakers are:
- Dr. Sandra Zaugg Kunz, Head Regulatory Assessment Deputy Head of Medicinal Product Authorisation and Vigilance, Swissmedic
- Elisabeth Leimbacher, Global Legal Lead, Marketing and Commercial Excellence, Takeda
- Celine Fang, Senior Antitrust Counsel, Novartis
The discussion will be moderated by Josefine Sommer and Anne Robert, Partner, Sidley.
AGENDA
5:30 p.m. – Arrival and registration
6:00 p.m. – Panel discussion and Q&A
7:30 p.m. – Networking and apéro riche
For more information, please contact gvaevents@sidley.com.
Click here to join the Women’s Life Sciences Network LinkedIn Group.
For more information about previous editions, please click here.
